Recombinant Full-Length Hepatitis C Virus E1E2 Dimer Elicits Pangenotypic Neutralizing Antibodies

An effective prophylactic vaccine would be beneficial for controlling and eradicating hepatitis C virus (HCV) infections. However, the high diversity across HCV genotypes is a major challenge for vaccine development. Selection of the appropriate immunogen is critical to elicit broad HCV neutralizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tianli, Chi, Xiaojing, Liu, Xiuying, Pan, Shengnan, Chen, Wenfang, Duan, Huarui, Zhang, Xinhui, Yang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273934/
https://www.ncbi.nlm.nih.gov/pubmed/35837406
http://dx.doi.org/10.3389/fimmu.2022.831285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273934/
https://www.ncbi.nlm.nih.gov/pubmed/35837406
http://dx.doi.org/10.3389/fimmu.2022.831285

Ejemplares similares